Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
-
Argus Upgrades Amgen (AMGN) to Buy
-
Argus Downgrades Amgen (AMGN) to Hold
-
Notable Analyst Rating Changes 03/06: (OVTI) (RBCN) (MWW) Upgraded; (NLY) (NVS) (LULU) Downgraded
-
Notable Analyst Rating Changes 11/04: KIM, PHM, QCOM, HMA Upgraded; MPWR, PT, SWIR, K Downgraded
-
Argus Upgrades Amgen (AMGN) to Buy
-
Amgen (AMGN) Shares Upgraded to Buy at Argus; Stock Now Well Into Positive Territory
-
David Moenning's Daily State of the Markets: 1/27

